Biggest moves
Q2 2026, quarter ended Jun 30Deep Track opened $248.3M of Alnylam Pharmaceuticals in Q2 2026.
A new position, 3.6% of the 13F value at Jun 30.
Calls and puts in grey: an option is not a buy or a sale of the stock, and its amount is as filed, mostly the value of the shares underneath. Every filed line is in the list below.

